Open Access

Seminal plasma piRNA array analysis and identification of possible biomarker piRNAs for the diagnosis of asthenozoospermia

  • Authors:
    • Ling He
    • Xingwu Wu
    • Rongye Wu
    • Ping Guo
    • Wenfeng He
    • Wanlei Sun
    • He Chen
  • View Affiliations

  • Published online on: March 23, 2022     https://doi.org/10.3892/etm.2022.11275
  • Article Number: 347
  • Copyright: © He et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Asthenozoospermia (AZS) is characterized by reduced sperm motility and its pathogenesis remains poorly understood. Piwi‑interacting RNAs (piRNAs) have been indicated to serve important roles in spermatogenesis. However, little is known about the correlation of piRNA expression with AZS. In the present study, small RNA sequencing (small RNA‑seq) was performed on sperm samples from AZS patients and fertile controls. Reverse transcription‑quantitative (RT‑q) PCR was used to validate the small RNA‑seq results. Bioinformatics analyses were performed to predict the functions of differentially expressed piRNAs (DEpiRNAs). Logistic regression models were constructed and receiver operating characteristic curve (ROC) analysis was used to evaluate their diagnostic performance. A total of 114 upregulated and 169 downregulated piRNAs were detected in AZS patients. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses showed that the DEpiRNAs were mainly associated with transcription, signal transduction, cell differentiation, metal ion binding and focal adhesion. These results were verified by RT‑qPCR analysis of eight selected piRNAs. The PCR results were consistent with the sequencing results in patients with AZS compared with controls in the first cohort. The expression of piR‑hsa‑32694, piR‑hsa‑26591, piR‑hsa‑18725 and piR‑hsa‑18586 was significantly upregulated in patients with AZS. The diagnostic power of the four piRNAs was further analyzed using ROC analysis; piR‑hsa‑26591 exhibited an area under the ROC curve (AUC) of 0.913 (95% CI: 0.795‑0.994). Logistic regression modelling and subsequent ROC analysis indicated that the combination of the 4 piRNAs achieved good diagnostic efficacy (AUC: 0.935).
View Figures
View References

Related Articles

Journal Cover

May-2022
Volume 23 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
He L, Wu X, Wu R, Guo P, He W, Sun W and Chen H: Seminal plasma piRNA array analysis and identification of possible biomarker piRNAs for the diagnosis of asthenozoospermia. Exp Ther Med 23: 347, 2022
APA
He, L., Wu, X., Wu, R., Guo, P., He, W., Sun, W., & Chen, H. (2022). Seminal plasma piRNA array analysis and identification of possible biomarker piRNAs for the diagnosis of asthenozoospermia. Experimental and Therapeutic Medicine, 23, 347. https://doi.org/10.3892/etm.2022.11275
MLA
He, L., Wu, X., Wu, R., Guo, P., He, W., Sun, W., Chen, H."Seminal plasma piRNA array analysis and identification of possible biomarker piRNAs for the diagnosis of asthenozoospermia". Experimental and Therapeutic Medicine 23.5 (2022): 347.
Chicago
He, L., Wu, X., Wu, R., Guo, P., He, W., Sun, W., Chen, H."Seminal plasma piRNA array analysis and identification of possible biomarker piRNAs for the diagnosis of asthenozoospermia". Experimental and Therapeutic Medicine 23, no. 5 (2022): 347. https://doi.org/10.3892/etm.2022.11275